Diabetes, metabolic disease, and telomere length

Feifei Cheng, Luke Carroll, Mugdha V. Joglekar, Andrzej S. Januszewski, Kwun Kiu Wong, Anandwardhan A. Hardikar, Alicia J. Jenkins, Ronald C. W. Ma

Research output: Contribution to journalArticlepeer-review

139 Citations (Scopus)

Abstract

Telomeres are regions of repetitive nucleotide sequences at the ends of chromosomes. Telomere length is a marker of DNA damage, which is often considered a biomarker for biological ageing, and has also been linked with cardiovascular disease, diabetes, and cancer. Emerging studies have highlighted the role of genetic and environmental factors, and explored the effect of modulating telomere length. We provide an overview of studies to date on diabetes and telomere length, and compare different methods and assays for evaluating telomere length and telomerase activity. We highlight the limitations of current studies and areas that warrant further research to unravel the link between diabetes and telomere length. The value of adding telomere length to clinical risk factors to improve risk prediction of diabetes and related complications also merits further investigation.
Original languageEnglish
Pages (from-to)117-126
Number of pages10
JournalLancet Diabetes and Endocrinology
Volume9
Issue number2
DOIs
Publication statusPublished - Feb 2021

Bibliographical note

Publisher Copyright:
© 2021 Elsevier Ltd

Fingerprint

Dive into the research topics of 'Diabetes, metabolic disease, and telomere length'. Together they form a unique fingerprint.

Cite this